Show
Sort by
-
- Journal Article
- A1
- open access
Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis
-
- Journal Article
- A1
- open access
Optimizing therapy in primary biliary cholangitis : alkaline phosphatase at six months identifies one-year non-responders and predicts survival
-
- Journal Article
- A1
- open access
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis : ENHANCE, a phase 3, randomized, placebo-controlled study
-
- Journal Article
- A1
- open access
Factors associated with progression and outcomes of early stage primary biliary cholangitis
-
Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response
-
Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis
-
Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies
-
Derivation of a machine learning model to predict clinical outcome in patients with primary biliary cholangitis
-
Obeticholic acid for the treatment of non-alcoholic steatohepatitis : interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
-
Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis : risk factors and time trends in incidence and outcome
-
Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history
-
Alkaline phosphatase normalization is associated with a decreased risk for liver transplantation and death in patients with primary biliary cholangitis
-
Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival
-
Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment
-
Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients
-
Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients
-
The GLOBE score identifies PBC patients at increased risk of liver transplantation or death during follow-up
-
Association between ursodeoxycholic acid therapy and prolonged transplant-free survival among patients with primary biliary cholangitis a number needed to treat analysis